Insider Purchases: Inside the Buy
Tag: insider buying
Badger Meter (BMI) Stock Analysis 2026: Insider Buys After 24% Crash 💧📉
Badger Meter just took a 24% hit—but the CEO is buying the dip. With strong long-term water infrastructure trends and improved valuation, is BMI a hidden opportunity or just treading water?
🛡️ Okta (OKTA): The AI Identity Moat Is Getting Cheaper
Okta is no longer just a high-growth story—it’s becoming a profitable identity powerhouse in the age of AI. With improving margins, strong institutional backing, and a new insider buy, the question is simple: is this a turnaround… or just the beginning?
📈 Top 10 Insider Buys April 2026: CEOs Buying OSCR, NKE, LW & More
CEOs, directors, and 10% owners are writing real checks again. From Oscar Health’s massive $11.9M buy to Nike’s continued dip-buying, here are the most interesting insider moves of April 2026.
Nike (NKE) Stock: Insiders Keep Buying the Dip—Should You? 👟
Nike (NKE) has fallen sharply from its highs, but insider buying, strong brand equity, and improved valuation are turning heads. Is this the start of a comeback—or a trap?
CEO Bets $11.9M: Is Oscar Health (OSCR) About to Shock the Market? 🚀
Oscar Health (OSCR) is no longer just a flashy disruptor—it’s aiming for profitability. With CEO Mark Bertolini buying $11.9M in stock and revenue projected to hit $19B in 2026, this could be one of the most compelling turnaround plays in healthcare.
Top 10 Insider Buys April 2026: Where CEOs Are Investing Millions Now 📈
When CEOs, directors, and 10% owners buy millions of dollars of their own stock, it’s worth paying attention. Here are the top insider buys of April 2026—and why MGM, PANW, AHCO, and others stand out.
Phreesia (PHR): Profitable… Then Crushed — Why Insiders Are Loading Up
Phreesia just hit profitability—and got punished for it. With insiders loading up and institutions fully committed, is this a classic overreaction or a value trap? Let’s decode the dip.
📈 CME Group Stock Analysis 2026: A Near-Monopoly at Record Highs
CME Group is the “house that always wins” in financial markets. A dominant, cash-generating business—but at current prices, patience may pay off.
PANW Stock Analysis 2026: Why CEO Nikesh Arora Just Bet $10M on Palo Alto Networks 🛡️
PANW is the “Microsoft of cybersecurity”—dominant, profitable, and growing fast. But with premium valuation and heavy institutional ownership, is now the right time to buy?
Lululemon (LULU): 68% Off — Bargain or Value Trap? 🧘
Lululemon (LULU) has fallen sharply from its highs, but insider buying and international growth suggest opportunity. Is this a contrarian buy—or a value trap in disguise?